DK0973501T3 - Vandig suspension til nasal indgivelse af loteprednol - Google Patents

Vandig suspension til nasal indgivelse af loteprednol

Info

Publication number
DK0973501T3
DK0973501T3 DK98900360T DK98900360T DK0973501T3 DK 0973501 T3 DK0973501 T3 DK 0973501T3 DK 98900360 T DK98900360 T DK 98900360T DK 98900360 T DK98900360 T DK 98900360T DK 0973501 T3 DK0973501 T3 DK 0973501T3
Authority
DK
Denmark
Prior art keywords
loteprednol
aqueous suspension
nasal administration
nasal
administration
Prior art date
Application number
DK98900360T
Other languages
Danish (da)
English (en)
Inventor
Koji Doi
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of DK0973501T3 publication Critical patent/DK0973501T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK98900360T 1997-01-16 1998-01-14 Vandig suspension til nasal indgivelse af loteprednol DK0973501T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1966497 1997-01-16
PCT/JP1998/000108 WO1998031343A2 (en) 1997-01-16 1998-01-14 Aqueous suspension for nasal administration of loteprednol

Publications (1)

Publication Number Publication Date
DK0973501T3 true DK0973501T3 (da) 2004-01-19

Family

ID=12005518

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98900360T DK0973501T3 (da) 1997-01-16 1998-01-14 Vandig suspension til nasal indgivelse af loteprednol

Country Status (32)

Country Link
US (1) US6368616B1 (id)
EP (1) EP0973501B1 (id)
KR (1) KR100471708B1 (id)
CN (1) CN1126535C (id)
AR (1) AR011773A1 (id)
AT (1) ATE249205T1 (id)
AU (1) AU730953C (id)
BR (1) BR9806771A (id)
CA (1) CA2278025C (id)
CZ (1) CZ294919B6 (id)
DE (1) DE69818026T2 (id)
DK (1) DK0973501T3 (id)
EA (1) EA001775B1 (id)
ES (1) ES2206880T3 (id)
HU (1) HU226613B1 (id)
ID (1) ID21892A (id)
IL (1) IL130979A0 (id)
LT (1) LT4677B (id)
LV (1) LV12449B (id)
MX (1) MXPA99006628A (id)
NO (1) NO324619B1 (id)
NZ (2) NZ509908A (id)
PL (1) PL190753B1 (id)
PT (1) PT973501E (id)
RS (1) RS49701B (id)
SI (1) SI20057A (id)
SK (1) SK283164B6 (id)
TR (1) TR199901663T2 (id)
TW (1) TW503113B (id)
UA (1) UA52722C2 (id)
WO (1) WO1998031343A2 (id)
ZA (1) ZA98303B (id)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6428805B1 (en) * 1998-08-26 2002-08-06 Teijin Limited Powdery nasal compositions
DE19947235A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US6565832B1 (en) * 2000-01-31 2003-05-20 Schering-Plough Healthcare Products, Inc. Spray composition with reduced dripping
KR100988542B1 (ko) * 2001-06-18 2010-10-20 노벤 파머수티컬즈, 인코퍼레이티드 경피 시스템에서의 강화된 약물 전달
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
DE602004008083T2 (de) * 2003-06-19 2008-04-24 Nicholas S. Gainsville Bodor Verstärkung der aktivität und/oder wirkdauer von ausgewählten entzündungshemmenden steroiden
WO2005000317A1 (en) 2003-06-19 2005-01-06 Bodor Nicholas S Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application
US20050095205A1 (en) * 2003-10-31 2005-05-05 Ramesh Krishnamoorthy Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
WO2005094836A2 (en) 2004-03-25 2005-10-13 Bausch & Lomb Incorporated Use of loteprednol etabonate for the treatment of dry eye
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
WO2007058935A2 (en) * 2005-11-14 2007-05-24 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
KR20140069210A (ko) 2011-09-22 2014-06-09 보오슈 앤드 롬 인코포레이팃드 안과적 겔 조성물
KR102665710B1 (ko) 2017-08-24 2024-05-14 노보 노르디스크 에이/에스 Glp-1 조성물 및 그 용도
JP7761567B2 (ja) 2020-02-18 2025-10-28 ノヴォ ノルディスク アー／エス 医薬製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
EP0709099A3 (en) * 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액

Also Published As

Publication number Publication date
CN1250370A (zh) 2000-04-12
SK283164B6 (sk) 2003-03-04
HK1026138A1 (en) 2000-12-08
CZ294919B6 (cs) 2005-04-13
NZ336990A (en) 2001-03-30
CN1126535C (zh) 2003-11-05
AR011773A1 (es) 2000-09-13
NZ509908A (en) 2004-12-24
PT973501E (pt) 2004-02-27
UA52722C2 (uk) 2003-01-15
ID21892A (id) 1999-08-05
US6368616B1 (en) 2002-04-09
MXPA99006628A (es) 2005-01-10
LV12449B (en) 2000-09-20
NO324619B1 (no) 2007-11-26
IL130979A0 (en) 2001-01-28
EP0973501A2 (en) 2000-01-26
ATE249205T1 (de) 2003-09-15
EA001775B1 (ru) 2001-08-27
DE69818026D1 (de) 2003-10-16
ES2206880T3 (es) 2004-05-16
HU226613B1 (en) 2009-04-28
BR9806771A (pt) 2000-05-16
CZ237499A3 (cs) 2000-01-12
CA2278025C (en) 2005-09-06
AU730953C (en) 2002-02-07
KR20000070214A (ko) 2000-11-25
NO993453L (no) 1999-07-13
WO1998031343A3 (en) 1998-09-17
PL334614A1 (en) 2000-03-13
ZA98303B (en) 1998-07-20
SI20057A (sl) 2000-04-30
KR100471708B1 (ko) 2005-03-07
WO1998031343A2 (en) 1998-07-23
PL190753B1 (pl) 2006-01-31
CA2278025A1 (en) 1998-07-23
TR199901663T2 (xx) 1999-09-21
DE69818026T2 (de) 2004-07-08
NO993453D0 (no) 1999-07-13
SK94899A3 (en) 2000-05-16
HUP0002473A2 (hu) 2000-12-28
LT4677B (lt) 2000-07-25
TW503113B (en) 2002-09-21
YU36199A (sh) 2002-09-19
EA199900659A1 (ru) 2000-02-28
EP0973501B1 (en) 2003-09-10
LT99100A (en) 2000-02-25
LV12449A (lv) 2000-04-20
HUP0002473A3 (en) 2001-01-29
AU730953B2 (en) 2001-03-22
AU5495298A (en) 1998-08-07
RS49701B (sr) 2007-12-31

Similar Documents

Publication Publication Date Title
DK0973501T3 (da) Vandig suspension til nasal indgivelse af loteprednol
DE69831421D1 (de) Zusammensetzungen zur nasalen verabreichung
DE69624405D1 (de) Nasenmaske
NO20003161D0 (no) Blandinger for nasal administrasjon av kannabinoider
DE60028845D1 (de) Nasale Beatmungsmaske
ID25629A (id) AMINA BISIKLIK (Pecahan dari P-961362)
DE69819387D1 (de) Kehlkopfmaske
DE69815569D1 (de) Kehlkopfmaske
DK1129741T3 (da) Forstövningsindretning til inhalator
IS5245A (is) Lyfjablanda úr ómeprasól
ATE151622T1 (de) Nasaler dilatator
DE69816858D1 (de) Beatmungssystem
IT1284049B1 (it) Medicamento per somministrazione nasale
NO962103D0 (no) Nasal-applikator
IT1295352B1 (it) Apparecchio per doccia nasale micronizzata
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
IS5487A (is) Innúðatæki
AU144045S (en) Nasal mask
DE69816736D1 (de) Nasale Inhaliervorrichtung
NO985936D0 (no) Nasal administrasjon av desmopressin
AU144046S (en) Nasal mask
EP0975363A4 (en) Attenuated respiratory syncytial virus
DE60021297D1 (de) Nasaler Dilatator
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
DK1019058T3 (da) Farmaceutisk suspension omfattende hemihydratet af nevirapin